UCLA Health

At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.

September 23, 2024

2024 ESMO Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub

Insights from 2023 ESMO Annual Meeting

Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

Insights from 2023 ASCO® Annual Meeting

Insights from 2023 ASCO® Annual Meeting

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Conference Coverage

ASH 2022 Conference Coverage

N. Pouratian

Login

Login

Join VuMedi

ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineligible MIBC With Durvalumab + Tremelimumab + Enfortumab Vedotin

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results From the …

Different Uses of Efanesoctocog Alfa in Hemophilia A: Prophylaxis, P…

ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineli…

Best of ASCO® Los Angeles 2024: DIPPER Trial - Adjuvant PD-1 Blockad…

Best of ASCO® Los Angeles 2024: The PATHWay Trial - Adjuvant Pembro …

Best of ASCO® Los Angeles 2024: E3311 ECOG-ACRIN Trial - Transoral S…

ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy o…

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs…

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenan…

AACR 2024 Insights: "IMvoke010 - Comparing Atezolizumab to Placebo A…

HERTHENA-Lung01 Study: Patritumab Deruxtecan as a HER3 Target in EGF…

Managing Advanced Prostate Cancer Pts in Urology Clinics and When to…

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Y90 Radioembolization for Locally Advanced HCC

2024 Updates in Locally Advanced Cervical Cancer

Updates in Endometrial Cancer

ESMO 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Docetaxel i…

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOL…

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combinati…

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribo…

Recurrent Cervical Cancer Updates

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With At…

ASH 2022 Once Weekly Selinexor, Carfilzomib & Dexamethasone (XKd) in…

Recurrent Cervical Cancer: Updates on Management

Importance of Thoughtful Testing for PIK3CA Mutations in HR+ MBC

Efficacy of Datopotamab Deruxtecan in mNSCLC and Actionable Genomic …

Impact of Androgen Deprivation Therapy Use and Duration With Definit…

ASCO 2021 Highlights on the Outcomes in Patients ≥ 65 Years in the A…

Treatment Advances in mTNBC Personalized Care: Clinical & Molecular …

ASCO 2021 Updates on Advanced NSCLC: Dose Analysis of the TROP2-Dire…

How I Treat Esophageal Cancer in 2021: Changing Landscape of Localiz…

Advanced Esophageal Cancer Updates: Considering Efficacy Data for 1L…

A Case of Stage 3 Distal EAC & ESCC: Considering Pembro+dCRT & Tirag…

2021 Updates on Esophageal Cancer: How Important Is Genomic Profilin…

Prostate Cancer PET Imaging Biological Target: FACBC vs PSMA PET/CT …

PSMA PET Imaging for Primary Staging: Efficacy Analysis of Methods f…

PSMA PET/CT Imaging in Prostate Cancer: GALLIUM-68 vs FLUOR-18 PSMA-…

2020 ASCO Update on mCRPC: What Is the OS After 177Lu-PSMA-617 Molec…

Latest Updates for Meningiomas

Laser Ablation of Brain Tumors

Immunotherapy and Clinical Trials for Brain Tumors

Brain Metastases: Management and Challenging Cases

Brain Mapping for Glioma Surgery

Metastatic Bladder Cancer Beyond Immune Checkpoint Inhibitors: Antib…

Metastatic Bladder Cancer Beyond Immune Checkpoint Inhibitors: Chemo…